Perna Francesco, Casella Michela, Narducci Maria Lucia, Dello Russo Antonio, Bencardino Gianluigi, Pontone Gianluca, Pelargonio Gemma, Andreini Daniele, Vitulano Nicola, Pizzamiglio Francesca, Conte Edoardo, Crea Filippo, Tondo Claudio
Francesco Perna, Maria Lucia Narducci, Gianluigi Bencardino, Gemma Pelargonio, Nicola Vitulano, Filippo Crea, Cardiac Arrhythmia Unit, Agostino Gemelli University Hospital, 00168 Rome, Italy.
World J Cardiol. 2016 Apr 26;8(4):310-6. doi: 10.4330/wjc.v8.i4.310.
The growing number of atrial fibrillation catheter ablation procedures warranted the development of advanced cardiac mapping techniques, such as image integration between electroanatomical map and cardiac computed tomography. While scanning the chest before catheter ablation, it is frequent to detect cardiac and extracardiac collateral findings. Most collateral findings are promptly recognized as benign and do not require further attention. However, sometimes clinically relevant collateral findings are detected, which often warrant extra diagnostic examinations or even invasive procedure, and sometimes need to be followed-up over time. Even though reporting and further investigating collateral findings has not shown a clear survival benefit, almost all the working groups providing data on collateral findings reported some collateral findings eventually coming out to be malignancies, sometimes at an early stage. Therefore, there is currently no clear agreement about the right strategy to be followed.
心房颤动导管消融手术数量的不断增加,促使了先进心脏标测技术的发展,比如电解剖图与心脏计算机断层扫描之间的图像整合。在导管消融术前扫描胸部时,经常会检测到心脏和心脏外的附带发现。大多数附带发现会立即被认定为良性,无需进一步关注。然而,有时会检测到具有临床相关性的附带发现,这往往需要额外的诊断检查甚至侵入性手术,有时还需要长期随访。尽管报告和进一步研究附带发现并未显示出明显的生存获益,但几乎所有提供附带发现数据的工作组都报告称,有些附带发现最终被证实为恶性肿瘤,有时还是早期阶段。因此,目前对于应遵循的正确策略尚无明确共识。